Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid

Details for Australian Patent Application No. 2006285963 (hide)

Owner Kissei Pharmaceutical Co., Ltd.

Inventors Kobayashi, Mamoru; Asari, Tetsuya

Agent Griffith Hack

Pub. Number AU-A-2006285963

PCT Pub. Number WO2007/026630

Priority 2005-247563 29.08.05 JP

Filing date 28 August 2006

Wipo publication date 8 March 2007

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/195 (2006.01)

A61K 31/216 (2006.01)

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/026630 Priority application(s): WO2007/026630

22 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006285971-Method for electrolysis of molten salt, electrolytic cell, and process for producing Ti using said method

2006285940-Synthetic resin square bottle body